# A Study of Patients Receiving High-Dose Rate Brachytherapy

> **NCT00924027** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 43 (actual)

## Conditions studied

- Cervical Cancer
- Endometrial Cancer
- Esophageal Cancer
- Prostate Cancer
- Biliary Cancer

## Interventions

- **RADIATION:** High Dose Radiation (HDR) Brachytherapy
- **DIAGNOSTIC_TEST:** MRI
- **DIAGNOSTIC_TEST:** CT
- **DIAGNOSTIC_TEST:** PET Scan

## Key facts

- **NCT ID:** NCT00924027
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-14
- **Primary completion:** 2024-05-28
- **Final completion:** 2025-07-24
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924027, "A Study of Patients Receiving High-Dose Rate Brachytherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00924027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*